如何评估 gMG 治疗效果？哪些情况可判定治疗失败?

参考文献：

[1] 中国免疫学会神经免疫分会.中国重症肌无力诊断和治疗指南(2020 版)[J].中国神经免疫学和神经病学杂志,2021,28(1):1-12.

[2] Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg. 2000;70(1):327-334. doi:10.1016/s0003-4975(00)01595-2

[3] 李海峰. 重症肌无力治疗策略的演变及个体化治疗路径 [J] . 中华医学杂志, 2021, 101(31) : 2492-2496. DOI: 10.3760/cma.j.cn112137-20210125-00237.

[4] 陈伟茜,张莹.难治性重症肌无力的治疗新进展[J].中风与神经疾病杂志,2019,(第 9 期)：855-857.

[5] Zust C, Morren JA. What are the treatment options for myasthenia gravis if first-line agents fail?. Cleve Clin J Med. 2023;90(2):81-84. Published 2023 Feb 1. doi:10.3949/ccjm.90a.22022